CVS HEALTH Corp Quarterly Costs and Expenses in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
CVS HEALTH Corp quarterly/annual Costs and Expenses history and growth rate from Q1 2018 to Q3 2024.
  • CVS HEALTH Corp Costs and Expenses for the quarter ending September 30, 2024 was $94.6B, a 9.9% increase year-over-year.
  • CVS HEALTH Corp Costs and Expenses for the twelve months ending September 30, 2024 was $359B, a 7.67% increase year-over-year.
  • CVS HEALTH Corp annual Costs and Expenses for 2023 was $344B, a 9.39% increase from 2022.
  • CVS HEALTH Corp annual Costs and Expenses for 2022 was $315B, a 12.8% increase from 2021.
  • CVS HEALTH Corp annual Costs and Expenses for 2021 was $279B, a 9.42% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $359B $94.6B +$8.52B +9.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $351B $88.2B +$2.5B +2.92% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $348B $86.2B +$4.33B +5.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $344B $90.4B +$10.3B +12.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-07
Q3 2023 $334B $86.1B +$996M +1.17% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $333B $85.7B +$9.72B +12.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $323B $81.8B +$8.55B +11.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $315B $80.2B +$5.93B +7.98% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-07
Q3 2022 $309B $85.1B +$14.3B +20.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $294B $76B +$7.68B +11.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $287B $73.3B +$7.76B +11.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $279B $74.3B +$7.23B +10.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-07
Q3 2021 $272B $70.7B +$6.93B +10.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $265B $68.3B +$7.63B +12.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $257B $65.5B +$2.22B +3.51% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $255B $67B +$3.18B +4.98% Oct 1, 2020 Dec 31, 2020 8-K 2023-05-25
Q3 2020 $252B $63.8B +$1.93B +3.11% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $250B $60.7B +$562M +0.94% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $249B $63.3B +$4.34B +7.36% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $245B $63.9B +$10.3B +19.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-09
Q3 2019 $235B $61.9B +$17B +37.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $218B $60.1B +$11.8B +24.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $206B $59B +$15.2B +34.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $191B $53.6B Oct 1, 2018 Dec 31, 2018 10-K 2021-02-16
Q3 2018 $44.9B Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $48.3B Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $43.7B Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.